The SVIN-Trial-Just Another Brick in the Wall?
作者信息
Mehtani Rohit
机构信息
Department of Hepatology, Amrita Institute of Medical Sciences and Research Centre, Faridabad, Haryana, India.
出版信息
J Clin Exp Hepatol. 2025 Mar-Apr;15(2):102449. doi: 10.1016/j.jceh.2024.102449. Epub 2024 Oct 30.
Abstract
摘要
相似文献
1
The SVIN-Trial-Just Another Brick in the Wall?
J Clin Exp Hepatol. 2025 Mar-Apr;15(2):102449. doi: 10.1016/j.jceh.2024.102449. Epub 2024 Oct 30.
2
Is cognitive motor dissociation just a minimally conscious state "plus" by another name?
medRxiv. 2025 Jun 18:2025.06.11.25329346. doi: 10.1101/2025.06.11.25329346.
3
Emerging adults' neuroticism links with depressive symptoms through personal belief in a just world and forgiveness.
Front Psychol. 2025 Jun 18;16:1489371. doi: 10.3389/fpsyg.2025.1489371. eCollection 2025.
4
Human exposure to pollutant emissions from brick kilns and their association with ocular health and neurotoxic symptoms: a pilot study in the Refugio Brickmaking Area, León, Mexico.
Front Psychiatry. 2025 Jun 13;16:1554101. doi: 10.3389/fpsyt.2025.1554101. eCollection 2025.
5
Patient-controlled analgesia with remifentanil versus alternative parenteral methods for pain management in labour.
Cochrane Database Syst Rev. 2017 Apr 13;4(4):CD011989. doi: 10.1002/14651858.CD011989.pub2.
6
Interventions to prevent or treat heavy menstrual bleeding or pain associated with intrauterine-device use.
Cochrane Database Syst Rev. 2022 Aug 26;8(8):CD006034. doi: 10.1002/14651858.CD006034.pub3.
7
Therapeutic ultrasound for carpal tunnel syndrome.
Cochrane Database Syst Rev. 2012 Jan 18;1:CD009601. doi: 10.1002/14651858.CD009601.
8
Implementing Just Culture to Improve Patient Safety.
Mil Med. 2022 May 18. doi: 10.1093/milmed/usac115.
9
A Brief Engagement Intervention Adapted for Racial and Ethnic Minority Young Adults in Mental Health Services: Protocol for a Pilot Optimization Trial.
JMIR Res Protoc. 2025 Jun 17;14:e68885. doi: 10.2196/68885.
10
Bladder training for urinary incontinence in adults.
Cochrane Database Syst Rev. 2004;2004(1):CD001308. doi: 10.1002/14651858.CD001308.pub2.
本文引用的文献
1
A Prospective Randomised Comparative Four-arm Intervention Study of Efficacy and Safety of Saroglitazar and Vitamin E in Patients With Non-alcoholic Fatty Liver Disease (NAFLD)/Non-alcoholic Steatohepatitis (NASH)-SVIN TRIAL.
J Clin Exp Hepatol. 2024 Sep-Oct;14(5):101398. doi: 10.1016/j.jceh.2024.101398. Epub 2024 Mar 18.
2
A Phase 3, Randomized, Controlled Trial of Resmetirom in NASH with Liver Fibrosis.
N Engl J Med. 2024 Feb 8;390(6):497-509. doi: 10.1056/NEJMoa2309000.
3
Efficacy and safety of saroglitazar in real-world patients of non-alcoholic fatty liver disease with or without diabetes including compensated cirrhosis: A tertiary care center experience.
JGH Open. 2023 Feb 20;7(3):215-220. doi: 10.1002/jgh3.12878. eCollection 2023 Mar.
4
Indian National Association for Study of the Liver (INASL) Guidance Paper on Nomenclature, Diagnosis and Treatment of Nonalcoholic Fatty Liver Disease (NAFLD).
J Clin Exp Hepatol. 2023 Mar-Apr;13(2):273-302. doi: 10.1016/j.jceh.2022.11.014. Epub 2022 Dec 7.
5
Saroglitazar for Nonalcoholic Fatty Liver Disease: A Single Centre Experience in 91 Patients.
J Clin Exp Hepatol. 2022 Mar-Apr;12(2):435-439. doi: 10.1016/j.jceh.2021.06.015. Epub 2021 Jun 19.
6
Safety and Efficacy of Saroglitazar in Nonalcoholic Fatty Liver Patients With Diabetic Dyslipidemia-A Prospective, Interventional, Pilot Study.
J Clin Exp Hepatol. 2022 Jan-Feb;12(1):61-67. doi: 10.1016/j.jceh.2021.03.012. Epub 2021 Apr 9.
7
Saroglitazar, a PPAR-α/γ Agonist, for Treatment of NAFLD: A Randomized Controlled Double-Blind Phase 2 Trial.
Hepatology. 2021 Oct;74(4):1809-1824. doi: 10.1002/hep.31843. Epub 2021 Jul 19.
8
Saroglitazar in patients with non-alcoholic fatty liver disease and diabetic dyslipidemia: a prospective, observational, real world study.
Sci Rep. 2020 Dec 3;10(1):21117. doi: 10.1038/s41598-020-78342-x.
9
A Phase 2 Double Blinded, Randomized Controlled Trial of Saroglitazar in Patients With Nonalcoholic Steatohepatitis.
Clin Gastroenterol Hepatol. 2021 Dec;19(12):2670-2672. doi: 10.1016/j.cgh.2020.10.051. Epub 2020 Nov 2.
10
An Observational Study of Reduction in Glycemic Parameters and Liver Stiffness by Saroglitazar 4 mg in Patients With Type 2 Diabetes Mellitus and Nonalcoholic Fatty Liver Disease.
Cureus. 2020 Jul 8;12(7):e9065. doi: 10.7759/cureus.9065.
Zotero 插件